309 related articles for article (PubMed ID: 14985328)
21. Interactions between MAP kinase and oestrogen receptor in human breast cancer.
McGlynn LM; Tovey S; Bartlett JM; Doughty J; Cooke TG; Edwards J
Eur J Cancer; 2013 Apr; 49(6):1176-86. PubMed ID: 23265704
[TBL] [Abstract][Full Text] [Related]
22. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
[TBL] [Abstract][Full Text] [Related]
23. Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation.
Martin LA; Farmer I; Johnston SR; Ali S; Marshall C; Dowsett M
J Biol Chem; 2003 Aug; 278(33):30458-68. PubMed ID: 12775708
[TBL] [Abstract][Full Text] [Related]
24. Proximal events in signaling by plasma membrane estrogen receptors.
Razandi M; Pedram A; Park ST; Levin ER
J Biol Chem; 2003 Jan; 278(4):2701-12. PubMed ID: 12421825
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks.
Banerjee S; Sengupta K; Saxena NK; Dhar K; Banerjee SK
Mol Cancer Res; 2005 Mar; 3(3):151-62. PubMed ID: 15798095
[TBL] [Abstract][Full Text] [Related]
26. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of Gefitinib-mediated reversal of tamoxifen resistance in MCF-7 breast cancer cells by inducing ERα re-expression.
Zhang X; Zhang B; Liu J; Liu J; Li C; Dong W; Fang S; Li M; Song B; Tang B; Wang Z; Zhang Y
Sci Rep; 2015 Feb; 5():7835. PubMed ID: 25644501
[TBL] [Abstract][Full Text] [Related]
28. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
Wu W; Pew T; Zou M; Pang D; Conzen SD
J Biol Chem; 2005 Feb; 280(6):4117-24. PubMed ID: 15590693
[TBL] [Abstract][Full Text] [Related]
29. Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation.
Geraldes P; Sirois MG; Tanguay JF
Circ Res; 2003 Sep; 93(5):399-405. PubMed ID: 12893737
[TBL] [Abstract][Full Text] [Related]
30. Fibronectin and type IV collagen activate ERalpha AF-1 by c-Src pathway: effect on breast cancer cell motility.
Sisci D; Aquila S; Middea E; Gentile M; Maggiolini M; Mastroianni F; Montanaro D; Andò S
Oncogene; 2004 Nov; 23(55):8920-30. PubMed ID: 15467744
[TBL] [Abstract][Full Text] [Related]
31. Gαo potentiates estrogen receptor α activity via the ERK signaling pathway.
Bratton MR; Antoon JW; Duong BN; Frigo DE; Tilghman S; Collins-Burow BM; Elliott S; Tang Y; Melnik LI; Lai L; Alam J; Beckman BS; Hill SM; Rowan BG; McLachlan JA; Burow ME
J Endocrinol; 2012 Jul; 214(1):45-54. PubMed ID: 22562654
[TBL] [Abstract][Full Text] [Related]
32. Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane.
Razandi M; Alton G; Pedram A; Ghonshani S; Webb P; Levin ER
Mol Cell Biol; 2003 Mar; 23(5):1633-46. PubMed ID: 12588983
[TBL] [Abstract][Full Text] [Related]
33. Ligand-independent coactivation of ERalpha AF-1 by steroid receptor RNA activator (SRA) via MAPK activation.
Deblois G; Giguère V
J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):123-31. PubMed ID: 12943696
[TBL] [Abstract][Full Text] [Related]
34. Mitogen-activated protein kinase (MAPK) pathway mediates the oestrogen-like activities of ginsenoside Rg1 in human breast cancer (MCF-7) cells.
Lau WS; Chen WF; Chan RY; Guo DA; Wong MS
Br J Pharmacol; 2009 Apr; 156(7):1136-46. PubMed ID: 19298253
[TBL] [Abstract][Full Text] [Related]
35. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
Filardo EJ; Quinn JA; Frackelton AR; Bland KI
Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440
[TBL] [Abstract][Full Text] [Related]
36. Delayed activation of extracellular-signal-regulated kinase 1/2 is involved in genistein- and equol-induced cell proliferation and estrogen-receptor-alpha-mediated transcription in MCF-7 breast cancer cells.
Liu H; Du J; Hu C; Qi H; Wang X; Wang S; Liu Q; Li Z
J Nutr Biochem; 2010 May; 21(5):390-6. PubMed ID: 19427779
[TBL] [Abstract][Full Text] [Related]
37. Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via extracellularly signal-regulated kinase signaling and can be abrogated by estrogen.
Zheng A; Kallio A; Härkönen P
Endocrinology; 2007 Jun; 148(6):2764-77. PubMed ID: 17363451
[TBL] [Abstract][Full Text] [Related]
38. Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells.
Hutcheson IR; Knowlden JM; Madden TA; Barrow D; Gee JM; Wakeling AE; Nicholson RI
Breast Cancer Res Treat; 2003 Sep; 81(1):81-93. PubMed ID: 14531500
[TBL] [Abstract][Full Text] [Related]
39. The food contaminants bisphenol A and 4-nonylphenol act as agonists for estrogen receptor alpha in MCF7 breast cancer cells.
Vivacqua A; Recchia AG; Fasanella G; Gabriele S; Carpino A; Rago V; Di Gioia ML; Leggio A; Bonofiglio D; Liguori A; Maggiolini M
Endocrine; 2003 Dec; 22(3):275-84. PubMed ID: 14709801
[TBL] [Abstract][Full Text] [Related]
40. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
